GlassScriptPhysician profile
Beatrice Saintard
NPI 1093339996
$1,955.08
in general payments reported to CMS, 2019-2025
14 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.78 · 2022: $470 · 2023: $339 · 2024: $706 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $715.63 | 2022-2025 | Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $417.57 | 2022-2024 | Keytruda |
| Eisai INC. | $151.16 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $144.93 | 2022-2024 | Lynparza |
| Genmab U.S., INC. | $139.53 | 2021-2024 | Tivdak |
| Sumitomo Pharma America, INC. | $108.41 | 2024-2025 | Gemtesa |
| Vertex Pharmaceuticals Incorporated | $58.43 | 2024-2025 | |
| Clovis Oncology, INC. | $51.17 | 2022 | |
| Abbvie INC. | $39.03 | 2024-2025 | |
| Photocure INC | $36.38 | 2024 | Cysview |
| Travere Therapeutics, INC. | $36.21 | 2025 | |
| Ferring Pharmaceuticals INC. | $23.05 | 2024 | Adstiladrin |
| Exact Sciences Corporation | $20.26 | 2025 | Cologuard Collection Kit |
| Dova Pharmaceuticals | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatrice Saintard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.